Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
4
Jiayu Holding
300117
5
Wuxi Taclink Optoelectronics Technology
688205
US Stock MarketDetailed Quotes
UTHR United Therapeutics
- 371.280
- +3.310+0.90%
Close Jan 22 16:00 ET
- 371.280
- 0.0000.00%
Post 16:20 ET
16.58BMarket Cap16.31P/E (TTM)
373.880High366.200Low318.21KVolume371.370Open367.970Pre Close118.27MTurnover0.78%Turnover Ratio18.74P/E (Static)44.64MShares417.81552wk High2.72P/B15.20BFloat Cap208.62552wk Low--Dividend TTM40.93MShs Float417.815Historical High--Div YieldTTM2.09%Amplitude4.275Historical Low371.686Avg Price1Lot Size
About United Therapeutics Company
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Company Profile
SymbolUTHR
Company NameUnited Therapeutics
Listing DateJun 17, 1999
Issue Price12.00
Founded1996
CEODr. Martine A. Rothblatt, J.D.,M.B.A.,PhD
MarketNASDAQ
Employees1168
Fiscal Year Ends12-31
Address1000 Spring Street
CitySilver Spring
ProvinceMaryland
CountryUnited States of America
Zip Code20910
Phone1-301-608-9292
Websitehttp://www.unither.com
Company Executives
- Name
- Position
- Salary
- Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD
- Chairperson of the Board Chief Executive Officer
- 16.96M
- James C. Edgemond
- Chief Financial Officer, Principal Accounting Officer and Treasurer
- 6.05M
- Michael Benkowitz
- President and Chief Operating Officer
- 9.81M
- Paul A. Mahon,J.D.
- Executive Vice President, General Counsel and Corporate Secretary
- 5.15M
- Christopher Patusky,J.D.
- Vice Chairman of the Board and Lead Independent Director
- 532.60K
- Christopher Causey,M.B.A.
- Independent Director
- 481.54K
- Raymond C. Kurzweil
- Independent Director
- 457.60K
- Raymond Dwek,F.R.S.
- Independent Director
- 456.54K
- Nilda Mesa, J.D.
- Independent Director
- 487.60K
- Richard Giltner
- Independent Director
- 513.66K
- Dr. Louis W. Sullivan, M.D.
- Independent Director
- 471.54K
- Governor Tommy G. Thompson
- Independent Director
- 456.54K
- Dr. Linda Maxwell, M.B.A.,M.D.
- Independent Director
- 456.54K
- Jan Malcolm
- Independent Director
- --
- Dr. Judy D. Olian, PhD
- Independent Director
- 488.66K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
December CPI comes in as expected, is that enough?
U.S. December CPI rose 2.9% year-on-year, aligning with expectations but marking a three-month inflation increase trend. The market reacted
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart